Using Ultra Low Frequency Neuromodulation to Treat Chronic Low Back Pain

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial aims to evaluate the effectiveness and safety of Ultra Low Frequency (ULF) neuromodulation in treating nociceptive chronic low back pain in adults. Participants will be randomly assigned to receive either ULF therapy combined with conventional medical management or conventional treatments alone. The study will monitor participants over a 24-month period, assessing pain relief and any unexpected medical issues that arise. The primary endpoint will be evaluated at 3 months, with an option for participants to switch treatment arms if necessary.

Why it matters

Who can join: the full rules

Inclusion Criteria:

1. Chronic, intractable nociceptive axial low back pain with or without leg pain (VAS ≥6 cm for back pain over 7 days) for a minimum of 3 months.
2. Symptoms have failed to respond adequately to conservative therapies, including: physical therapy/exercise, medications, and interventional therapies.
3. Back pain greater than leg pain.
4. ODI score ≥30 and ≤80.
5. On stable pain medications or on no pain medications.
6. Considered medically stable and a suitable surgical candidate.
7. Able to operate the device.
8. Willing to sign the Human Research Ethics Committee (HREC)/Institutional Review Board (IRB) approved informed consent form.
9. Willing and deemed capable of complying with the requirements of the study protocol, including attending all scheduled visits.
10. Twenty-two (22) years of age or older.
11. Able to complete questionnaires independently.

Exclusion Criteria:

1. Have a systemic condition or disease not stabilized or judged by the investigator to be incompatible with participation in the study.
2. Suffer from severe cognitive impairment that would impair ability to complete subject questionnaires or operation of the device.
3. Diagnosed with an active disruptive psychological or psychiatric disorder or other known condition significant enough to impact perception of pain, compliance, intervention and/or ability to evaluate treatment outcome as assessed by a clinical psychologist or psychiatrist.
4. Presence of spinal stenosis, structural spinal abnormality, or spinal instrumentation observed on MRI or CT that would make lead placement unsafe or untowardly difficult.
5. Previous experience with neuromodulation devices for pain.
6. Opioid usage with average total daily morphine equivalent dose (MED) of \>100 mg.
7. Have an untreated addiction to alcohol or other drugs within 6 months of screening visit.
8. Have a cardiac demand pacemaker, implanted defibrillator, or another implanted electronic device.
9. Have a known hypersensitivity to any of the procedural agents or materials in the study device that is inserted into the subject.
10. Have a known need for an MRI or surgery through the end of the study.
11. Candidates of child-bearing potential cannot be pregnant nor plan to become pregnant during the study.
12. Diagnosed with untreated malicious or malignant neoplasms or have a life expectancy of less than 1 year.
13. Be participating in another interventional clinical trial.

Where it's running

• The International Spine Centre
  Norwood, South Australia, Australia Recruiting
• CerCare Pty Ltd
  Wayville, South Australia, Australia Recruiting
• Monash House Research Centre
  Clayton, Victoria, Australia Recruiting

Study contacts

• Study coordinator: Valerie Cimmarusti
• Email: vcimmarusti@presidiomedical.com
• Phone: +1 (626) 353-8667

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Esmolol vs Dexmedetomidine for opioid-sparing in laparoscopic gynecologic surgery

  This study tests whether low-dose esmolol or dexmedetomidine, given during surgery, reduces opioid use and improves pain control after laparoscopic hysterectomy compared with placebo.

  Recruiting National and Kapodistrian University of Athens · Athens · NCT07846722

• Using the Nociception Level Index to guide opioid dosing during combined regional and general anesthesia

  This trial tests whether using a Nociception Level Index (NOL) monitor to guide opioid dosing during combined general and regional anesthesia can reduce opioid use and side effects for adults having elective trauma or orthopedic surgery.

  Recruiting Universitätsklinikum Hamburg-Eppendorf · Hamburg · NCT06905340

• Investigating pain mechanisms in patients with spinal cord injuries

  This study is trying to understand how spinal cord injuries cause nerve pain by looking at how the body processes pain and responds to it in people with different types of spinal injuries and nerve issues.

  Recruiting University of Zurich · Zurich, Canton of Zurich · NCT06443281

• Using PET/MRI scans to find sources of chronic pain

  This study is testing if special PET/MRI scans can help find out where chronic pain comes from in people who have ongoing pain after joint surgeries compared to those without pain.

  Recruiting University of Wisconsin, Madison · Madison, Wisconsin · NCT06171659

• Monitoring and understanding chronic pain using AI and telemonitoring

  This study is testing a new way to manage chronic pain by using wearable technology and AI to better understand patients' pain experiences and improve their treatment.

  Recruiting at 4 sites ETH Zurich · Pietra Ligure, Savona and 3 other locations · NCT06044584

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.